Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Trials. 2020 Nov 17;21(1):927. doi: 10.1186/s13063-020-04877-z.


An amendment to this paper has been published and can be accessed via the original article.

Publication types

  • Published Erratum